Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Retifanlimab (anti-PD-1)
Price:
Purity: 95.0%
Stocking Period: 10 Day
Contact: Yang

2079108-44-2

2079108-44-2 structure

2079108-44-2 structure

Name: Retifanlimab
Chemical Name: Retifanlimab
CAS Number: 2079108-44-2
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Immunology/Inflammation PD-1/PD-L1
Create Date: 2023-04-14 21:08:24
Modify Date: 2024-04-06 12:25:58
Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA)[1].

Name	Retifanlimab

Description	Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA)[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Immunology/Inflammation >> PD-1/PD-L1
References	[1]. D V T Catenacci, et al. Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A. ESMO Open. 2022 Oct;7(5):100563.

No Any Chemical & Physical Properties